Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dipyridamole dose-escalation schemes added to aspirin for secondary stroke prevention
NL-OMON36298Active, not recruiting
- Sponsor
- Albert Schweitzer Hospital
- Start
- May 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of dipyridamole and aspirin in stroke and transient ischaemic attack (TIA) (2 arms), sponsored by Albert Schweitzer Hospital. Primary endpoint: Headache frequency. Started May 2012; status: active, not recruiting.
02
Drugs
dipyridamoleaspirin
03
Conditions
stroketransient ischaemic attack (TIA)
Beyond the preview
Go deeper on NL-OMON36298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36298.